A penny stock is a stock priced below $1. As a chartist you dont need indicators. You want to stay within volume. When you become a chartist it doesnt matter what industry you are in. In penny stocks make sure the price is affordable. In case look at the top left to the bottom right. Be a chartist and look at price direction. As Timothy Sykes says dont buy...
Ebola’s rising cases in Uganda are triggering the Who. Any Cases in Europe or the Usa will squeeze this ticket. Short Shares availabilities is declining Patience
The asset has now arrived at a great load-zone. The asset's recent volume has been more than average and currently sitting behind a major resistance labeled as R1. The butterfly pattern on the lower time frame is indicating the following targets in case a breakout of the R1 takes place.
GeoVax Labs, Inc. (NASDAQ: GOVX) is a clinical-stage biotech company with an impressive pipeline of vaccines and immunotherapies targeting cancer and infectious diseases using its proprietary technology platform. After the WHO declared monkeypox spread a global health emergency, monkeypox related stocks surged – with GOVX stock climbing more than 150%. As the...
Could fall hard if it breaks below this channel. Just watching for now to see that it does.
GOVX GeoVax Labs is a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer. GeoVax Labs will report Q1 2022 financial results on April 27. Jason McCarthy from Maxim Group has a $10.00 price target for GOVX. The stock is now $1.01. Market Cap of only 7.23Mil. This is a 4X upside potential short term stock in my opinion.
There was no change in my chart since last post. The retracement path followed as projected. Picked up some today for low risk entry. This is a keeper for a year time frame. Will scale in over next couple of months. 1st take profit around $7.40 (88% Fib level) and $10 for longer term outlook.
Still a keeper. The selling can continue but would be adding on intervals. $7.25 is the first target and could retest ATH eventually.
govx long after support 200 and 50 ma .... ahead of presentation disclaimer
govx support before the conference at 200 and 50 MA . long disclaimer
$GOVX looks like it has bottomed and is about to make a strong reversal to the upside. Key levels and dates on the chart. I think we could see somewhere between 6x-12x upside from here. Once we break the blue trendline, the next level to break is $7.91. Over $7.91 and I think we should see $30-60 by the end of the year. Break each level to the upside and should...
GOVX shares continue to trade in an upward trend posture, which has been in place since late last year and was recently further boosted by the stock's move above its long-term 200-day moving average.
Super bullish, breaking 6-month high. Python Algo signaling major move to upside. Fibs agree going over $12+
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its development of a vaccine against SARS-CoV-2, the virus that causes...
GOVX - Accumulation? - Strange Vol. - Covid Play - 10.8.20